Michał Szczyrek

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Patient Reported

Prognostic Factors

Chemotherapy Induced

Top Venues

Journal of clinical medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Marcin Mazurek, Sylwia Chocholska, Martyna Podgajna, Michał Szczyrek, Iwona Homa-Mlak, Teresa Małecka-Massalska, Marek Hus
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells 11 (4) (2022)
Michał Szczyrek, Anna Grenda, Barbara Kuźnar-Kamińska, Paweł Krawczyk, Marek Sawicki, Halina Batura-Gabryel, Radosław Mlak, Aneta Szudy-Szczyrek, Tomasz Krajka, Andrzej Krajka, Janusz Milanowski
Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer. Cancers 13 (23) (2021)
Michał Szczyrek, Radosław Mlak, Aneta Szudy-Szczyrek, Karolina Kędziora, Teresa Malecka-Massalska, Paweł Krawczyk, Janusz Milanowski
Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer. Journal of clinical medicine 10 (5) (2021)
Aneta Szudy-Szczyrek, Radosław Mlak, Magdalena Bury-Kamińska, Michał Mielnik, Martyna Podgajna, Kinga Kuśmierczuk, Marcin Mazurek, Iwona Homa-Mlak, Michał Szczyrek, Janusz Krawczyk, Teresa Malecka-Massalska, Marek Hus
Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients. British journal of haematology 191 (1) (2020)